(Q40112102)

17 September 2017

1 reference

reason for preferred rank

title

Progress toward therapeutic application of interferons, 1979–1983 (English)

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

29 August 2023

Progress toward therapeutic application of interferons, 1979-1983 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208992

29 August 2023

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

29 August 2023

author name string

E. C. Borden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208992

29 August 2023

language of work or name

English

0 references

publication date

1 December 1984

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

29 August 2023

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

29 August 2023

1 reference

17 September 2017

54

1 reference

17 September 2017

11 Suppl

1 reference

17 September 2017

2770-2776

1 reference

Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial

17 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819841201%2954%3A2%2B%3C2770%3A%3AAID-CNCR2820541425%3E3.0.CO%3B2-0

Efficacy of combined interferon cyclophosphamide therapy after diagnosis of lymphoma in AKR mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819841201%2954%3A2%2B%3C2770%3A%3AAID-CNCR2820541425%3E3.0.CO%3B2-0

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819841201%2954%3A2%2B%3C2770%3A%3AAID-CNCR2820541425%3E3.0.CO%3B2-0

The nucleotide sequence of a cloned human leukocyte interferon cDNA.

21 January 2018

1

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

The nucleotide sequence of human fibroblast interferon cDNA

29 August 2023

2

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Isolation and structure of a human fibroblast interferon gene

29 August 2023

3

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Human leukocyte interferon produced by E. coli is biologically active

29 August 2023

4

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Human leukocyte and fibroblast interferons are structurally related

29 August 2023

5

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

The structure of one of the eight or more distinct chromosomal genes for human interferon-α

29 August 2023

6

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

The structure of eight distinct cloned human leukocyte interferon cDNAs

29 August 2023

7

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Expression of human immune interferon cDNA in E. coli and monkey cells.

29 August 2023

8

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Interferon-gamma: success, structure and speculation

29 August 2023

9

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Partial purification and characterization of human gamma (immune) interferon

29 August 2023

10

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Biochimica et Biophysica Acta

29 August 2023

12

695

49

Taylor-Papadimitriou

1982

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells

29 August 2023

13

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Biochemistry of Interferons and Their Actions

29 August 2023

14

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases

29 August 2023

15

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

A unique set of polypeptides is induced by γ interferon in addition to those induced in common with α and β interferons

29 August 2023

17

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Enhanced expression of HLA antigens and β2-microglobulin on interferon-treated human lymphoid cells

29 August 2023

19

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells

29 August 2023

20

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial

29 August 2023

21

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Comparison of effects of leukocyte and fibroblast interferon on immunological parameters in cancer patients

29 August 2023

22

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Noncycling Tumor Cells Are Sensitive Targets for the Antiproliferative Activity of Human Interferon

29 August 2023

23

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon

29 August 2023

24

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture

29 August 2023

25

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Human interferon inhibits the growth of established human breast tumours in the nude mouse

29 August 2023

28

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X-ray-transformed C3H/10T1/2 cells under prolonged treatment with interferon

29 August 2023

29

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

29 August 2023

Cancer Treatment Reports

31

62

1899

Horoszewicz

1978

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Human lymphoblastoid interferon can inhibit the growth of human breast cancer xenografts in athymic (nude) mice

29 August 2023

32

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Induction and kinetics of natural killer cells in humans following interferon therapy

29 August 2023

37

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes

29 August 2023

41

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures

29 August 2023

42

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Annals of Internal Medicine

29 August 2023

44

182

96

Gutterman

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

29 August 2023

Toxicity of interferon.

45

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Target cell specificity of two species of human interferon-alpha produced in Escherichia coli and of hybrid molecules derived from them

29 August 2023

46

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Comparison of the Antiviral Activities of Various Cloned Human Interferon- Subtypes in Mammalian Cell Cultures

29 August 2023

47

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humans

29 August 2023

48

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma

29 August 2023

49

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Adjuvant Interferon Treatment of Human Osteosarcoma

29 August 2023

51

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors.

29 August 2023

55

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

29 August 2023

Cancer Treatment Reports

56

62

1899

Horoszewicz

1978

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Brief communication: Cure of murine leukemia with drug and interferon treatment.

29 August 2023

58

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Texas Reports on Biology and Medicine

29 August 2023

61

41

626

Gutterman

1983

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

29 August 2023

Cancer Treatment Reports

62

67

1009

Chaplinski

1983

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid Syndrome

29 August 2023

63

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Proceedings of the American Association for Cancer Research

29 August 2023

65

24

150

Silgals

1983

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Proceedings of the American Association for Cancer Research

29 August 2023

67

24

146

Kirkwood

1983

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Interferon therapy in myelomatosis

29 August 2023

70

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

29 August 2023

73

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML)

29 August 2023

77

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Alpha interferon for induction of remission in hairy-cell leukemia

29 August 2023

79

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Evaluation of human lymphoblastoid interferon in advanced malignant melanoma

29 August 2023

82

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

Site-specific mutagenesis of the human fibroblast interferon gene

29 August 2023

84

1 reference

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(19841201)54:2+%3C2770::AID-CNCR2820541425%3E3.0.CO;2-0

29 August 2023

Identifiers

10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO;2-0

1 reference

17 September 2017

1 reference